MINIMAL RESIDUAL DISEASE
Clinical trials for MINIMAL RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new MINIMAL RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for MINIMAL RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune booster: donor NK cells aim to cut cancer recurrence
Disease control Not yet recruitingThis trial tests whether adding natural killer (NK) cells from healthy donors to standard chemoradiotherapy can reduce the risk of cancer returning in people with advanced nasopharyngeal cancer. The study has two phases: first, finding the safest dose of NK cells, then testing th…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
Could Pre-Surgery chemo boost survival in colon cancer?
Disease control Not yet recruitingThis study compares giving chemotherapy before surgery versus standard surgery-first treatment for people with stage II or III colon cancer that has a high CEA level. About 100 adults aged 18-70 will be randomly assigned to one of two groups. The goal is to see if pre-surgery che…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 17, 2026 12:10 UTC
-
Blood test may predict liver cancer comeback and immunotherapy success
Knowledge-focused Not yet recruitingThis study looks at whether a blood test that detects tiny bits of tumor DNA (called minimal residual disease) can predict if liver cancer will come back after surgery. Researchers will test 276 patients before and after surgery to see if the test can also identify who might bene…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: NA • Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC